|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chaabane W, User SD, El-Gazzah M, Jaksik
R, Sajjadi E, Rzeszowska-Wolny J and Los MJ: Autophagy, apoptosis,
mitoptosis and necrosis: Interdependence between those pathways and
effects on cancer. Arch Immunol Ther Exp (Warsz). 61:43–58. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Su M, Mei Y and Sinha S: Role of the
crosstalk between autophagy and apoptosis in cancer. J Oncol.
2013:102735–102748. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Woodle ES and Kulkarni S: Programmed cell
death. Transplantation. 66:681–691. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rubinsztein DC, Gestwicki JE, Murphy LO
and Klionsky DJ: Potential therapeutic applications of autophagy.
Nat Rev Drug Discov. 6:304–312. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Periyasamy-Thandavan S, Jiang M,
Schoenlein P and Dong Z: Autophagy: Molecular machinery,
regulation, and implications for renal pathophysiology. Am J
Physiol Renal Physiol. 297:F244–F256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways of autophagy. Annu Rev Genet.
43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li JP, Yang YX, Liu QL, Pan ST, He ZX,
Zhang X, Yang T, Chen XW, Wang D, Qiu JX, et al: The
investigational Aurora kinase A inhibitor alisertib (MLN8237)
induces cell cycle G2/M arrest, apoptosis, and autophagy via p38
MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Drug Des Devel Ther. 9:1627–1652. 2015.PubMed/NCBI
|
|
9
|
Pan ST, Qin Y, Zhou ZW, He ZX, Zhang X,
Yang T, Yang YX, Wang D, Qiu JX and Zhou SF: Plumbagin induces G2/M
arrest, apoptosis, and autophagy via p38 MAPK- and
PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell
carcinoma cells. Drug Des Devel Ther. 9:1601–1626. 2015.PubMed/NCBI
|
|
10
|
Liu YL, Yang PM, Shun CT, Wu MS, Weng JR
and Chen CC: Autophagy potentiates the anti-cancer effects of the
histone deacetylase inhibitors in hepatocellular carcinoma.
Autophagy. 6:1057–1065. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang Q, Li F, Shi K, Yang Y and Xu C:
Sodium selenite-induced activation of DAPK promotes autophagy in
human leukemia HL60 cells. BMB Rep. 45:194–199. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang X, Chen LX, Ouyang L, Cheng Y and
Liu B: Plant natural compounds: Targeting pathways of autophagy as
anti-cancer therapeutic agents. Cell Prolif. 45:466–476. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Burada F, Nicoli ER, Ciurea ME, Uscatu DC,
Ioana M and Gheonea DI: Autophagy in colorectal cancer: An
important switch from physiology to pathology. World J Gastrointest
Oncol. 7:271–284. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Panossian A, Wikman G and Sarris J:
Rosenroot (Rhodiola rosea): Traditional use, chemical composition,
pharmacology and clinical efficacy. Phytomedicine. 17:481–493.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hung SK, Perry R and Ernst E: The
effectiveness and efficacy of Rhodiola rosea L.: A systematic
review of randomized clinical trials. Phytomedicine. 18:235–244.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Z, Li X, Simoneau AR, Jafari M and Zi
X: Rhodiola rosea extracts and salidroside decrease the growth of
bladder cancer cell lines via inhibition of the mTOR pathway and
induction of autophagy. Mol Carcinog. 51:257–267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tu Y, Roberts L, Shetty K and Schneider
SS: Rhodiola crenulata induces death and inhibits growth of breast
cancer cell lines. J Med Food. 11:413–423. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu X, Lin S, Yu D, Qiu S, Zhang X and Mei
R: A preliminary study: The anti-proliferation effect of
salidroside on different human cancer cell lines. Cell Biol
Toxicol. 26:499–507. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu X, Zhang X, Qiu S, Yu D and Lin S:
Salidroside induces cell-cycle arrest and apoptosis in human breast
cancer cells. Biochem Biophys Res Commun. 398:62–67. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu X, Peng X, Hu Z, Zhao Q, He J, Li J
and Zhong X: Effects of over-expression of ANXA10 gene on
proliferation and apoptosis of hepatocellular carcinoma cell line
HepG2. J Huazhong Univ Sci Technolog Med Sci. 32:669–674. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Li JZ, Lu AX, Zhang KF and Li BJ:
Anticancer effect of salidroside on A549 lung cancer cells through
inhibition of oxidative stress and phospho-p38 expression. Oncol
Lett. 7:1159–1164. 2014.PubMed/NCBI
|
|
22
|
Skopińska-Rózewska E, Malinowski M,
Wasiutyński A, Sommer E, Furmanowa M, Mazurkiewicz M and Siwicki
AK: The influence of Rhodiola quadrifida 50% hydro-alcoholic
extract and salidroside on tumor-induced angiogenesis in mice. Pol
J Vet Sci. 11:97–104. 2008.PubMed/NCBI
|
|
23
|
Sun C, Wang Z, Zheng Q and Zhang H:
Salidroside inhibits migration and invasion of human fibrosarcoma
HT1080 cells. Phytomedicine. 19:355–363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y, Yao Y, Wang H, Guo Y, Zhang H and
Chen L: Effects of salidroside on glioma formation and growth
inhibition together with improvement of tumor microenvironment.
Chin J Cancer Res. 25:520–526. 2013.PubMed/NCBI
|
|
25
|
Sun KX, Xia HW and Xia RL: Anticancer
effect of salidroside on colon cancer through inhibiting JAK2/STAT3
signaling pathway. Int J Clin Exp Pathol. 8:615–621.
2015.PubMed/NCBI
|
|
26
|
Wang XW and Zhang YJ: Targeting mTOR
network in colorectal cancer therapy. World J Gastroenterol.
20:4178–4188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Morgensztern D and McLeod HL:
PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer
Drugs. 16:797–803. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maira SM, Furet P and Stauffer F:
Discovery of novel anticancer therapeutics targeting the
PI3K/Akt/mTOR pathway. Future Med Chem. 1:137–155. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu P and Hu YZ: PI3K/Akt/mTOR pathway
inhibitors in cancer: A perspective on clinical progress. Curr Med
Chem. 17:4326–4341. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kabeya Y, Mizushima N, Ueno T, Yamamoto A,
Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a
mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tanida I, Minematsu-Ikeguchi N, Ueno T and
Kominami E: Lysosomal turnover, but not a cellular level, of
endogenous LC3 is a marker for autophagy. Autophagy. 1:84–91. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou ZW, Li XX, He ZX, Pan ST, Yang Y,
Zhang X, Chow K, Yang T, Qiu JX, Zhou Q, et al: Induction of
apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated
pathways by plumbagin in human prostate cancer cells. Drug Des
Devel Ther. 9:1511–1554. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tsai JP, Lee CH, Ying TH, Lin CL, Lin CL,
Hsueh JT and Hsieh YH: Licochalcone A induces autophagy through
PI3K/Akt/mTOR inactivation and autophagy suppression enhances
Licochalcone A-induced apoptosis of human cervical cancer cells.
Oncotarget. 6:28851–28866. 2015.PubMed/NCBI
|
|
34
|
Adams JM and Cory S: The Bcl-2 protein
family: Arbiters of cell survival. Science. 281:1322–1326. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Korsmeyer SJ: Regulators of cell death.
Trends Genet. 11:101–105. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang E and Korsmeyer SJ: Molecular
thanatopsis: A discourse on the BCL2 family and cell death. Blood.
88:386–401. 1996.PubMed/NCBI
|
|
37
|
Bar-Am O, Weinreb O, Amit T and Youdim MB:
Regulation of Bcl-2 family proteins, neurotrophic factors, and APP
processing in the neurorescue activity of propargylamine. FASEB J.
19:1899–1901. 2005.PubMed/NCBI
|
|
38
|
Hsuan SW, Chyau CC, Hung HY, Chen JH and
Chou FP: The induction of apoptosis and autophagy by Wasabia
japonica extract in colon cancer. Eur J Nutr. 55:491–503. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xie CM, Chan WY, Yu S, Zhao J and Cheng
CH: Bufalin induces autophagy-mediated cell death in human colon
cancer cells through reactive oxygen species generation and JNK
activation. Free Radic Biol Med. 51:1365–1375. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yim NH, Jung YP, Kim A, Ma CJ, Cho WK and
Ma JY: Oyaksungisan, a traditional herbal formula, inhibits cell
proliferation by induction of autophagy via JNK activation in human
colon cancer cells. Evid Based Complement Alternat Med.
2013:231874–231883. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang S, Wang X, Contino G, Liesa M, Sahin
E, Ying H, Bause A, Li Y, Stommel JM, Dell'antonio G, et al:
Pancreatic cancers require autophagy for tumor growth. Genes Dev.
25:717–729. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guo JY, Chen HY, Mathew R, Fan J,
Strohecker AM, Karsli-Uzunbas G, Kamphorst JJ, Chen G, Lemons JM,
Karantza V, et al: Activated Ras requires autophagy to maintain
oxidative metabolism and tumorigenesis. Genes Dev. 25:460–470.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ellington AA, Berhow MA and Singletary KW:
Inhibition of Akt signaling and enhanced ERK1/2 activity are
involved in induction of macroautophagy by triterpenoid B-group
soyasaponins in colon cancer cells. Carcinogenesis. 27:298–306.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gozuacik D and Kimchi A: Autophagy as a
cell death and tumor suppressor mechanism. Oncogene. 23:2891–2906.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ogier-Denis E and Codogno P: Autophagy: A
barrier or an adaptive response to cancer. Biochim Biophys Acta.
1603:113–128. 2003.PubMed/NCBI
|
|
47
|
Clarke PG: Developmental cell death:
Morphological diversity and multiple mechanisms. Anat Embryol
(Berl). 181:195–213. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kaser A and Blumberg RS: Autophagy,
microbial sensing, endoplasmic reticulum stress, and epithelial
function in inflammatory bowel disease. Gastroenterology.
140:1738–1747. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Klionsky DJ, Abdalla FC, Abeliovich H,
Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M,
Agostinis P, Aguirre-Ghiso JA, et al: Guidelines for the use and
interpretation of assays for monitoring autophagy. Autophagy.
8:445–544. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cao Y and Klionsky DJ: Physiological
functions of Atg6/Beclin 1: A unique autophagy-related protein.
Cell Res. 17:839–849. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Paglin S, Hollister T, Delohery T, Hackett
N, McMahill M, Sphicas E, Domingo D and Yahalom J: A novel response
of cancer cells to radiation involves autophagy and formation of
acidic vesicles. Cancer Res. 61:439–444. 2001.PubMed/NCBI
|
|
52
|
Petiot A, Ogier-Denis E, Blommaart EF,
Meijer AJ and Codogno P: Distinct classes of phosphatidylinositol
3′-kinases are involved in signaling pathways that control
macroautophagy in HT-29 cells. J Biol Chem. 275:992–998. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yamamoto A, Tagawa Y, Yoshimori T,
Moriyama Y, Masaki R and Tashiro Y: Bafilomycin A1 prevents
maturation of autophagic vacuoles by inhibiting fusion between
autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E
cells. Cell Struct Funct. 23:33–42. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A,
Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX, et al: Arenobufagin,
a natural bufadienolide from toad venom, induces apoptosis and
autophagy in human hepatocellular carcinoma cells through
inhibition of PI3K/Akt/mTOR pathway. Carcinogenesis. 34:1331–1342.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Rodon J, Dienstmann R, Serra V and
Tabernero J: Development of PI3K inhibitors: Lessons learned from
early clinical trials. Nat Rev Clin Oncol. 10:143–153. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang F, Wang Q, Zhou ZW, Yu SN, Pan ST, He
ZX, Zhang X, Wang D, Yang YX, Yang T, et al: Plumbagin induces cell
cycle arrest and autophagy and suppresses epithelial to mesenchymal
transition involving PI3K/Akt/mTOR-mediated pathway in human
pancreatic cancer cells. Drug Des Devel Ther. 9:537–560.
2015.PubMed/NCBI
|
|
57
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wang K, Liu R, Li J, Mao J, Lei Y, Wu J,
Zeng J, Zhang T, Wu H, Chen L, et al: Quercetin induces protective
autophagy in gastric cancer cells: Involvement of Akt-mTOR- and
hypoxia-induced factor 1α-mediated signaling. Autophagy. 7:966–978.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Shrivastava A, Kuzontkoski PM, Groopman JE
and Prasad A: Cannabidiol induces programmed cell death in breast
cancer cells by coordinating the cross-talk between apoptosis and
autophagy. Mol Cancer Ther. 10:1161–1172. 2011. View Article : Google Scholar : PubMed/NCBI
|
